Filing Details
- Accession Number:
- 0001209191-13-047610
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2013-10-07 15:21:48
- Reporting Period:
- 2013-08-13
- Filing Date:
- 2013-10-07
- Accepted Time:
- 2013-10-07 15:21:48
- Original Submission Date:
- 2013-08-15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 949858 | Oncogenex Pharmaceuticals Inc. | OGXI | In Vitro & In Vivo Diagnostic Substances (2835) | 954343413 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1442675 | Daniel Scott Cormack | 400-1001 W. Broadway Vancouver A1 V6H 4B1 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2013-08-19 | 3,112 | $8.68 | 60,238 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This amended Form 4 is filed to correct the transaction date, which was previously inadvertently reported as August 13, 2013.
- This amended Form 4 is filed to correct the transaction code, which was previously inadvertently reported as "F", and the sales price. The sales reported on this amended Form 4 were made for the sole purpose of covering the reporting person's tax liability in connection with the settlement of RSUs on August 19, 2013, which transaction was previously reported.
- This amended report is filed to correct the number of shares disposed of in connection with the sale of shares to satisfy the reporting person's tax liability in connection with the vesting of RSUs on August 13, 2013, which transaction was previously reported.
Billionaire Hedge Funds
